Epidemiology and prevalence of uveitis: Review of literature

Iranian Journal of Ophthalmology

Volumn 21, Issue 4, 2009, Pages 4-16

  Chams, Hormoz ^a   Rostami, Mohsen ^b   Mohammadi, S Farzad ^a   Ohno, Shigeaki ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Epidemiology; Global variation; Uveitis

Indexed keywords

EID: 73349112567     PISSN: 2345279x     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Nussenblatt RB. The natural history of uveitis. Int Ophthalmol 1990;14(5-6):303-8.
2. Darrell RW, Wagener HP, Kurland LT. Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol 1962;68:502-14.
3. Saari KM, Päivönsalo-Hietanen T, Vaahtoranta-Lehtonen H, et al. Epidemiology of endogenous uveitis in south-western Finland. Acta Ophthalmol Scand 1995;73(4):345-9.
4. Mercanti A, Parolini B, Bonora A, et al. Epidemiology of endogenous uveitis in north-eastern Italy. Analysis of 655 new cases. Acta Ophthalmol Scand 2001;79(1):64-8.
5. Päivönsalo-Hietanen T, Tuominen J, Vaahtoranta-Lehtonen H, Saari KM. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol Scand 1997;75(1):76-81.
6. Tran VT, Auer C, Guex-Crosier Y, et al. Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol 1994-1995;18(5):293-8.
7. Vadot E, Barth E, Billet P. Epidemiology of uveitis. Preliminary results of a prospective study in Savoy. In: Saari KM, ed. Uveitis update. Amsterdam: Elsevier Science Publishers, 1984,13-7.
8. Dandona L, Dandona R, John RK, et al. Population based assessment of uveitis in an urban population in southern India. Br J Ophthalmol 2000;84(7):706-9.
9. Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: the Northen California Epidemiology of Uveitis Study. Ophthalmology 2004;111(3):491-500.
10. Izawa Y, Namba K, Mochizuki M. Regarding uveitis statistics from Tokyo University ophthalmology and the visual prognosis of Behçet's disease patients. Jpn J Clin Ophthalmol 1981;35:855-60.
11. Chavis PS, Wafai MZ, Al-Amro S, et al. Uveitis in the Middle-East. In: Recent advances in uveitis. Dermouchamps JP, Verougstraete C, Caspers-velu L. Assignon MJ, eds. Amserdam:Kugler Publications,1983,149-56.
12. Islam SMM, Tabbara K. Causes of uveitis at the eye center in Saudi Arabia: A retrospective review. Ophthalmol Epidem 2002; 9(4):239-49.
13. Global leprosy situation, beginning of 2008. Weekly epidemiological record 2008;83(33):293-300. http://www.who.int/wer.
14. Rathinam SR, Rathnam S, Selvaraj S, et al. Uveitis associated with an epidemic outbreak of leptospirosis. Am J Ophthalmol 1997;124(1):71-9.
15. World Health Organization, Technical Report Series (WHO Expert Committee on Onchocerciasis, 3rd Report), No. 752, WHO, Geneva (1987).
16. Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol 1982;100(9):1455-8.
17. Mizuki N, Inoko H, Ando H, et al. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. Am J Ophthalmol 1993;116(4):406-9.
18. Rothova A, van Veenedaal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol 1987;103(2):137-45.
19. Brewerton DA, Caffrey M, Nicholls A, et al. Acute anterior uveitis and HL-A 27. Lancet 1973;302(7836):994-6.
20. Feltkamp TE. HLA and uveitis. Int Ophthalmol 1990;14(5-6):327-33.
21. KM, De Lay P. HIV/AIDS estimates and the quest for universal access. www.thelancet.com 2008;371:2068-9.
22. Holland GN. Acquired immunodeficiency syndrome and ophthalmology: the first decade. Am J Ophthalmol 1992;114(1):86-95.
23. Oruc S, Kaplan AD, Galen M, Kaplan HJ. Uveitis referral pattern in Midwest University Eye Center. Ocul Immunol Inflamm 2003;11(4):287-98.
24. McCannel CA, Holland GN, Helm CJ, et al. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 1996;121(1):35-45.
25. Yamamoto S, Sugita S, Sugamoto Y, et al. Quantitative PCR for the detection of genomic DNA of Epstein-Barr virus in ocular fluids of patients with uveitis. Jpn J Ophthalmol 2008;52(6):463-7.
26. Mochizuki M, Tajima K, Watanabe T, Yamaguchi K. Human T lymphotropic virus type 1 uveitis. Br. J Ophthalmol 1994:78(2):149-54.
27. Haut J. [Etiological classification of 850 cases of uveites]. Arch Ophtalmol Rev Gen Ophtalmol 1966;26(7):691-4. French.
28. Ducass A, Segal A, Mattot E, et al. Results of etiological investigations in uveitis. In: Ferraz de Olivera LN,ed. Ophthalmology Today, New York: Elsevier, 1988.395-399.
29. Vassileva P, Dimova PI, Parvova T, et al. Prevalence of uveitis in Sofia district. In: Recent advances in uveitis. Dernouchamps JP, Verougstraete C. Caspers-Velu L, Tassignon MJ, eds. Amsterdam: Kugler Publications, 1993,145-8.
30. Abiose A, Murdoch I, Babalola O, Cousens S, Liman I, Onyema J, Evans J, Gregory W, Jones B. Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol. 1994 Jan;78(1):8-13. Erratum in: Br J Ophthalmol 1995 Feb;79(2):197.
31. Newland HS, White AT, Greene BM, et al. Ocular manifestations of onchocerciasis in a rain forest area of west Africa. Br J Ophthalmol 1991;75(3):163-9.
32. Monjusiau AG, Lagraulet J, Dhaussy R, Goeckel CW. [Ophtalmological aspects of onchocerciasis in guatemala and west Africa]. Bull World Health Organ 1965;32:339-55. French.
33. Choyce DP. Onchocerciasis: ophthalmic aspects. Trans R Soc Trop Med Hyg 1966;60(6):720-6.
34. Rathinam SR, Cunningham ET Jr. Infectious causes of uveitis in the developing world. Int Ophthalmol Clin 2000;40(2):137-52.
35. Merle H, Cabre P, Olindo S, et al. Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type1 in martinique(French West Indies). Am J Ophthalmol 2002;134(2):190-5.
36. Yamamoto JH, Segurado AA, Hirata CE, et al. Human T-cell lymphotrophic virus type 1 infection and ocular manifestations in São Paulo, Brazil. Arch Ophthalmol 1999;117(4):513-7.
37. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol 2007;55(3):173-83.
38. Rathinam SR. Ocular leptospirosis. Curr Opin Ophthalmol 2002;13(6):381-6.
39. Bounlu K, Insisiengmay S, Vanthanouvong K, et al. Acute jaundice in Vientiane, Loa People's Democratic Republic. Clin Infect Dis 1998;27(4):717-21.
40. Park SK, Lee SH, Rhee YK, et al. Leptospirosis in Chonbuk Provice of Korea in 1987: a study of 93 patients. Am J Trop Med Hyg 1989;41(3):345-51.
41. Ko AI, Galvão Reis M, Ribeiro Dourado CM, et al. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 1999;354(9181):820-5.
42. Daubney R, Hudson JR, Garnham PC. Enzootic hepatitis or Rift Valley fever: An undescribed virus of sheep,cattle,and man from East Africa. J Pathol Bacteriol 1931;34:545-9.
43. Rathinam SR, Usha KR, Rao NA. Presumed trematode-induced granulomatous anterior uveitis: a newly recognized cause of intraocular inflammation in children from South India. Am J Ophthalmol 2002;133(6):773-9.
44. Nussenblatt RB, Lane HC. Human immunodeficiency virus disease: changing patterns of intraocular inflammation. Am J Ophthalmol 1998;125(3):374-82.
45. Jabs DA, Van Natta ML, Kempen JH, et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretrovirus therapy. Am J Ophthalmol 2002;133(1):48-61.
46. See RF, Rao NA. Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy. Ophthalmol Clin North Am 2002;15(4):529-36.
47. Centers for disease control and prevention. Summary of notifiable diseases-Unied States,1996. MMWR Morb Mortal Wkly Rep. 1997;45:1-87
48. Asbury T. The status of presumed ocular histoplasmosis: including a report of a survey. Trans Am Ophthalmol Soc 1996;64:371-400.
49. Smith RE, Ganley LP. An epidemiological study of presumed ocular histoplasmosis. Trans Am Acad Ophthalmol Otolaryngol 1971;75(5):994-1005.
50. de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol 2003;87(7):879-84.
51. Kadayifçilar S, Eldem B, Tumer B. Uveitis in childhood. J Pediatric Ophthalmol Strabismus 2003;40(6):335-40.
52. BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol 2005;89(4):444-8.
53. Chang JH, Wakefield D. Uveitis: a global perspective. Ocul Immunol Inflamm 2002;10(4):263-79.
54. Chatzistefanou K, Mackomichelakis NN, Christen W, et al. Characteristic of uveitis presenting for the first time in the elderly. Ophthalmology 1998;105(2):347-52
55. Merrill PT, Kim J, Cox TA, et al. Uveitis in southeastern United States. Curr Eye Res 1997;16(9):865-74.
56. Glasner PD, Silveria C, Kruzon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992;114(2):136-44.
57. Hill AV, Allsopp CE, Kwiatkowski D, et al. HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet 1992;337(8742):640-2.
58. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Arch Ophthalmol 1996;114(5):593-9.
59. Bodaghi B, Cassoux N, Wechsler B, et al. Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center. Medicine (Baltimore) 2001;80(4):263-70.
60. Reeves SW, Sloan FA, Lee PP, Jaffe GJ. Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort. Ophthalmology 2006;113(2):307.
61. Päivönsalo-Hietanen T, Tuominen J, Saari KM. Uveitis in children: population-based study in Finland. Acta ophthalmol Scand 2000;78(1):84-8.
62. Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm 2003;11(4):277-86.
63. Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 2005;30(11):943-8.
64. Singh R, Gupta V, Gupta A. Pattern of uveitis in referral eye clinic in North India. Indian J Ophthalmol 2004;52(2):121-5.
65. Soheilian M, Heidari K, Yazdani S, et al. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm 2004;12(4):297-310.
66. Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol 2008;15(5):285-93.
67. Khairallah M, Yahia SB, Ladjimi A, et al. Pattern of uveitis in referral center in Tunisia, North Africa. Eye 2007;21(1):33-9.
68. Couto C, Merlo JL. Epidemiological study on patients with uveitis in Buenos Aires, Argentina. In: Recent advances in uveitis. Dernouchamps JP, Verougstaete C, Caspers-velu L, Tassignon MJ, eds. Amsterdam:Kugler Publications,1993;171-4.
69. Shahram F, Davatchi F, Nadji A, et al. Recent epidemiological data on Behçet's disease in Iran. The 2001 survey. Adv Exp Med Biol 2003;528:31-6.
70. Jamshidi AR, Davatchi F, Tehrani Banihashemi A, et al. Prevalence of Behçet's disease in Iran, a WHO-ILAR COPCORD study. Rhreumatol 2006;24(suppl 42)S16.
71. Chams H, Lashey AR, Javadian A, et al. The risk factors and causes of blindness in Behçet's disease. Iranian J Ophthalmol 2008;20(2):15-19.